Vera Therapeutics Inc.
VERA | NASDAQ
$36.06
+$1.81 (+5.28%)
Sep 22, 2026, 2:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -10.87 | -15.38 | -6.84 | -5.78 | -11 | -0.80 |
PEG Ratio | -0.16 | -0.69 | 0.21 | -0.15 | 0.13 | 0 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.38 | 4.05 | 6.46 | 6.69 | 5.16 | -0.48 |
P/FCF Ratio | -13.46 | -17.25 | -7.12 | -7.60 | -15.14 | -1.22 |
P/OCF Ratio | -13.49 | -17.37 | -7.13 | -7.61 | -15.14 | -1.23 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.13 | 0.09 | 0.53 | 0.41 | 0.07 | 0 |
Quick Ratio | 13.64 | 25.67 | 7.71 | 4.91 | 10.73 | 22.55 |
Current Ratio | 13.64 | 25.67 | 7.71 | 4.91 | 10.73 | 22.55 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -41.89 | -21.92 | -26.94 | -91.64 | -1.72K | -289.52 |
Return on Equity | -49.56% | -26.36% | -94.40% | -115.80% | -46.86% | 59.78% |
Return on Assets | -40.78% | -23.20% | -54.68% | -67.76% | -38.94% | -97.91% |
Return on Invested Capital | -46.27% | -26.46% | -65.53% | -83.80% | -45.23% | -92.16% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove VERA